SEMNUR PHARMS (SMNR) Stock Price, News & Analysis
What Changed
- Semnur Pharmaceuticals (SMNR) faces cash squeeze, eyes $100M equity lifeline
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
Price Move History
- Daily moves over 5%
- 59 94 sessions, September 23, 2025 to September 18, 2026
- Largest daily move
- +122.2% close of December 17, 2025
Company Description
SEMNUR PHARMS (OTC: SMNR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $103.6M.
SMNR has declined 98.0% so far this year. The last closing price was $0.4500.
For FY2025, SEMNUR PHARMS and diluted earnings per share of -$0.78.
This page collects what Stock Titan holds for SMNR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SEMNUR PHARMS (SMNR) closed at $0.4500 on September 18, 2026. So far this year, the price has lost 98.0%.
SMNR Metrics & Rankings
Price returns through September 18, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEMNUR PHARMS has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all SMNR news →
SEC Filings
SEMNUR PHARMS has filed 3 recent SEC filings, including 1 Form 10-Q, 1 Form 424B3, 1 Form 8-K. The most recent filing was submitted on August 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
Diluted earnings per share stood at -$0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in SEMNUR PHARMS (SMNR) currently stands at 92.0 thousand shares, up 0.7% from the previous reporting period, representing 0.3% of the float. Since September 2025, short interest has increased by 5555.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for SEMNUR PHARMS (SMNR) currently stands at 4.9 days, down 40.6% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 50.2% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SMNR Company Profile & Sector Positioning
SEMNUR PHARMS (SMNR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.